Citadel Advisors’s AC Immune ACIU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $296K | Sell |
|
|||||
|
2025
Q1 | $283K | Buy |
|
|||||
|
2024
Q4 | $21.2K | Sell |
|
|||||
|
2024
Q3 | $82.4K | Sell |
|
|||||
|
2024
Q2 | $139K | Sell |
|
|||||
|
2024
Q1 | $180K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $3.13K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $7.41K | Sell |
|
|||||
|
2022
Q4 | $341K | Buy |
|
|||||
|
2022
Q3 | – | Hold |
|
|||||
|
2022
Q2 | – | Hold |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $127K | Sell |
|
|||||
|
2021
Q3 | $242K | Buy |
|
|||||
|
2021
Q2 | $172K | Sell |
|
|||||
|
2021
Q1 | $280K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $117K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $297K | Sell |
|
|||||
|
2019
Q4 | $700K | Sell |
|
|||||
|
2019
Q3 | $595K | Sell |
|
|||||
|
2019
Q2 | $924K | Buy |
|
|||||
|
2019
Q1 | $626K | Sell |
|
|||||
|
2018
Q4 | $4.25M | Buy |
|
|||||
|
2018
Q3 | $2.28M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $163K | Sell |
|
|||||
|
2017
Q4 | $993K | Hold |
|
|||||
|
2017
Q3 | $877K | Sell |
|
|||||
|
2017
Q2 | $1.24M | Sell |
|
|||||
|
2017
Q1 | $1.82M | Sell |
|
|||||
|
2016
Q4 | $4.85M | Buy |
|
|||||
|
2016
Q3 | $1.23M | Buy |
|